Last reviewed · How we verify

NCT07503847

Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49

ENROLLING BY INVITATION NA Last updated 31 March 2026
What this trial tests

NA trial testing Colonoscopy in Colo-rectal Cancer in 2,286 participants. Enrolling by invitation.

Timeline
1 September 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorNational Taiwan University Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposescreening
Enrollment2,286
Start date1 September 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

Adults 40 to 49, any sex, with Colo-rectal Cancer or Shared Decision Making. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study was to evaluate the impact of a constructed shared decision (SDM) intervention (offering an option between colonoscopy and immunochemical collapsible occult blood testing (fecal immunochemical test; FIT)) on improving the incidence of high colonoscopy stromal in patients aged 40-49 years with a close relative suffering from colorectal cancer, compared to standard care (direct referral for colonoscopy).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Colonoscopy

Trials testing the same drug.

Other recruiting trials for Colo-rectal Cancer

Currently open trials in the same condition.

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07503847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing